Target intelligence / Profile preview

PDGFA divergent transcript (PDGFA-DT)

Target
PDGFA-DT
Molecular classification
Other (Long non-coding RNA, lncRNA)
01

Overview

PDGFA divergent transcript (PDGFA-DT), also known as HRAT92 or heart tissue-associated transcript 92, is a long non-coding RNA gene located on chromosome 7 in humans. It is named for its genomic proximity and divergent orientation relative to the PDGFA gene (platelet-derived growth factor subunit A), but it is not a protein-coding gene, nor is it a receptor, enzyme, transporter, or other classical drug target. There is insufficient functional data and no established biological or disease roles in major databases as of the current knowledge. Based on available resources, it does not have recognized interacting drugs, biomarker status, or direct therapeutic relevance. The abbreviation PDGFA-DT may be confused with the platelet-derived growth factor A protein or its receptor genes (PDGFA, PDGFRA), which have well-characterized roles in cell signaling and cardiovascular biology. However, this particular entry refers to a distinct lncRNA (non-protein-coding) that is different from those established targets. Therefore, it is important not to conflate PDGFA-DT (PDGFA divergent transcript) with the PDGF family of proteins or receptors. In summary, the PDGFA divergent transcript is not a standard therapeutic target, but rather, it's an under-characterized noncoding RNA for which insufficient molecular or clinical detail is currently available to populate standard target fields.

Other names
HRAT92heart tissue-associated transcript 92
02

Biological functions

Unknown (No well-established functions as of the information available)
03

Disease associations

Unknown (There are no well-established links in major biomedical databases to a specific disease role)

Beyond the preview

Go deeper on PDGFA divergent transcript (PDGFA-DT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PDGFA divergent transcript (PDGFA-DT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call